Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rangering i aksjer #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aksjekurs
$59.98
Sist synkronisert: 2024-12-13
Markedsverdi
$1.22B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

EPS for Longboard Pharmaceuticals, Inc. (LBPH)
EPS per September 2024 TTM: $-2.24
Ifølge de siste økonomiske rapportene og aksjekursen til Longboard Pharmaceuticals, Inc. er selskapets nåværende EPS (TTM) $-2.24. Ved slutten av 2022 hadde selskapet en EPS på $-2.51, en økning sammenlignet med EPS-en i 2021 som var $-1.62.
EPS-historikk for Longboard Pharmaceuticals, Inc. fra 2020 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -873.21%
US
$27.74 -1,338.39%
NL
$-5.29 136.16%
AU
$-7.98 256.25%
US
- -
CH